Andrea Galbiati - Concepedia

Author

Andrea Galbiati

Philochem (Switzerland)ORCID

Also Known As

A Galbiati, A. Galbiati, Andrea Galbiati, GALBIATI, ANDREA

Publications

417

Citations

H-Index

Concepts

All Affiliations

Philochem (Switzerland)Philogen (Italy)École Polytechnique Fédérale de Lausanne University of Milan University Hospital Münster

About

Andrea Galbiati is an author at Philochem (Switzerland) specializing in tumor microenvironment, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	58
2	Biomolecular Engineering	1	1	37
3	Cell Biology	1	1	21
4	Molecular Biology	1	1	37
5	Pharmacology	1	1	21

Andrea Galbiati

Publications

341

Citations

H-Index

Page 1

	Year	Citations
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA Philipp Backhaus, F. Gierse, Matthias C. Burg, European Journal of Nuclear Medicine and Molecular Imaging	2021	91
A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake Andrea Galbiati, Aureliano Zana, Matilde Bocci, Journal of Nuclear Medicine	2022	62
Selective tumor targeting enabled by picomolar fibroblast activation protein inhibitors isolated from a DNA-encoded affinity maturation library Sara Puglioli, Eleonore Schmidt, Christian Pellegrino, Chem Drug TargetNovel TherapyDrug DiscoveryMolecular BiologySelective Tumor	2022	37
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors Aureliano Zana, Andrea Galbiati, Ettore Gilardoni, Clinical Cancer Research	2022	21
In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment Matilde Bocci, Aureliano Zana, Lucrezia Principi, Journal of Controlled Release Cell-based Drug DeliveryDrug TargetingTargeted DeliveryMedicineTubulin Poisons	2024	21
Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy Francesco Bartoli, Philip H. Elsinga, Luiza Reali Nazario, Pharmaceuticals	2022	18
Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention Andrea Galbiati, Matilde Bocci, Silvia Gervasoni, Journal of Medicinal Chemistry	2024	18
Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds Andrea Galbiati, Aureliano Zana, Consuelo Coser, ACS Medicinal Chemistry Letters	2021	15
Covalent Inhibitors of <i>Plasmodium falciparum</i> Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro Gregorio Cullia, Stefano Bruno, Silvia Parapini, ACS Medicinal Chemistry Letters	2019	14
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics Andrea Galbiati, Paulina Dorten, Ettore Gilardoni, Journal of Nuclear Medicine	2023	12

Page 1